In observance of Independence Day in the U.S., CenterWatch Weekly will not be published Monday, July 6. The next issue will be published Monday, July 13. Read More
The issues posed by the COVID-19 pandemic have led to a roughly 30 percent increase in site costs, with much of the increase stemming from sites being forced to quickly adopt remote monitoring and other measures in response to the crisis, experts say. Read More
More than half of the top 50 pharma sponsors have had to make protocol changes in their ongoing trials since the COVID-19 pandemic began, driving up volume at IRBs and sparking “remarkable growth” in clinical trials over the past three months. Read More
As the race to develop an effective COVID-19 vaccine by year’s end gains momentum, the FDA said it plans to issue a guidance on developing and licensing them. Read More
A majority of European clinical trials of COVID-19 drugs are being run by universities and companies who either lack experience or have a poor track record in uploading their results to the EU’s trial database, which could lead to wasted research, according to a new report. Read More
There is a new product available to help overcome blinding challenges in trials that makes it possible to administer a study drug without participants knowing whether they’re receiving the investigational product or placebo. Read More
